Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Aimmune Therapeutics, Inc.    AIMT

AIMMUNE THERAPEUTICS, INC.

(AIMT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société AIMMUNE THERAPEUTICS, INC.
10/19AIMMUNE THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Com..
AQ
10/19AIMMUNE THERAPEUTICS : Receives Positive CHMP Opinion on PALFORZIA for the Treat..
AQ
10/15MONTEVERDE & ASSOCIATES PC : Files Class Action Lawsuit On Behalf Of Shareholder..
PR
10/15AIMMUNE THERAPEUTICS : Nestle Completes Acquisition of Aimmune Therapeutics
AQ
10/13AIMMUNE THERAPEUTICS : Nestle announces results of tender offer for Aimmune Ther..
AQ
09/18Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics..
PR
09/15AIMMUNE THERAPEUTICS : Nestle commences tender offer for Aimmune Therapeutics In..
AQ
09/14AIMMUNE THERAPEUTICS : Nestlé commences tender offer for Aimmune Therapeutics, I..
PR
09/05KASKELA LAW LLC : Announces Stockholder Investigation of Aimmune Therapeutics, I..
PR
09/04AIMMUNE INVESTOR ALERT BY THE FORMER : Kahn Swick & Foti, LLC Investigates Adequ..
BU
09/01AIMMUNE THERAPEUTICS : Nestle to acquire Aimmune Therapeutics
AQ
09/01AIMMUNE THERAPEUTICS : Nestlé Health Science to acquire Aimmune Therapeutics for..
AQ
09/01AIMMUNE THERAPEUTICS : Enters Definitive Agreement with Societes des Produits Ne..
AQ
08/31WeissLaw LLP Investigates Aimmune Therapeutics, Inc.
PR
08/31Yum China, Aimmune rise; Regis, Walmart fall
AQ
08/31ALERT : Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therape..
BU
08/31(AIMT) ALERT : Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics..
PR
08/31AIMMUNE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulat..
AQ
08/31AIMMUNE THERAPEUTICS : Enters Definitive Agreement with Sociétés des Produits Ne..
BU
08/25AIMMUNE THERAPEUTICS : Largest European Qualitative Study on Peanut Allergy High..
AQ
08/24AIMMUNE THERAPEUTICS : Largest European Qualitative Study on Peanut Allergy High..
BU
08/10AIMMUNE THERAPEUTICS : to Present at the 2020 Wedbush PacGrow Healthcare Virtual..
AQ
08/07AIMMUNE THERAPEUTICS : to Present at the 2020 Wedbush PacGrow Healthcare Virtual..
BU
07/31AIMMUNE THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
07/30AIMMUNE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
07/30AIMMUNE THERAPEUTICS : 2Q Earnings Snapshot
AQ
07/30AIMMUNE THERAPEUTICS : Announces Second Quarter 2020 Financial Results and Provi..
BU
07/23AIMMUNE THERAPEUTICS : to Host Conference Call and Webcast to Discuss Second Qua..
BU
07/22AIMMUNE THERAPEUTICS : Full Results of Aimmune's Pivotal Phase 3 European ARTEMI..
AQ
07/21AIMMUNE THERAPEUTICS : Full Results of Aimmune's Pivotal Phase 3 European ARTEMI..
BU
07/06AIMMUNE THERAPEUTICS : Appoints Narinder Singh as Executive Vice President of Te..
BU
06/09AIMMUNE THERAPEUTICS : New Two-Year PALFORZIA Data Show On-going Safety and Effi..
AQ
06/09AIMMUNE THERAPEUTICS : New Data Show Patients Are Highly Satisfied With and Conf..
AQ
06/08AIMMUNE THERAPEUTICS : New Two-Year PALFORZIA™ Data Show On-going Safety a..
BU
06/08AIMMUNE THERAPEUTICS : New Data Show Patients Are Highly Satisfied With and Conf..
BU
06/04AIMMUNE THERAPEUTICS : to Present at the Goldman Sachs 41st Annual Global Health..
BU
06/02AIMMUNE THERAPEUTICS : New PALFORZIA Data on Long-Term Safety, Efficacy and Immu..
AQ
06/01AIMMUNE THERAPEUTICS : New PALFORZIA™ Data on Long-Term Safety, Efficacy a..
BU
05/29AIMMUNE THERAPEUTICS : Largest European Quantitative Study on Peanut Allergy Con..
AQ
05/28AIMMUNE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders..
AQ
05/28AIMMUNE THERAPEUTICS : Largest European Quantitative Study on Peanut Allergy Con..
BU
05/12AIMMUNE THERAPEUTICS : to Present at the RBC Capital Markets 2020 Global Healthc..
BU
05/11AIMMUNE THERAPEUTICS : 1Q Earnings Snapshot
AQ
05/11AIMMUNE THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
05/11AIMMUNE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
05/11AIMMUNE THERAPEUTICS : Announces First Quarter 2020 Financial Results and Provid..
BU
04/30AIMMUNE THERAPEUTICS : to Host Conference Call and Webcast to Discuss First Quar..
BU
04/08AIMMUNE THERAPEUTICS : to Present at the 19th Annual Needham Virtual Healthcare ..
BU
03/17AIMMUNE THERAPEUTICS : Announces First U.S. Patients Are Being Treated with Newl..
AQ
03/16AIMMUNE THERAPEUTICS : Announces New PALFORZIA Data Suggesting Increased Desensi..
AQ
03/16AIMMUNE THERAPEUTICS : Announces First U.S. Patients Are Being Treated with Newl..
BU
03/13AIMMUNE THERAPEUTICS : Announces New PALFORZIA™ Data Suggesting Increased ..
BU
02/27AIMMUNE THERAPEUTICS : 4Q Earnings Snapshot
AQ
02/27AIMMUNE THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
02/27AIMMUNE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
02/27AIMMUNE THERAPEUTICS : Announces Fourth Quarter and Full Year 2019 Financial Res..
BU
02/26AIMMUNE THERAPEUTICS : to Present at Upcoming Investor Conferences
BU
02/25AIMMUNE THERAPEUTICS : to Present New Clinical Data at AAAAI Annual Meeting
BU
02/20AIMMUNE THERAPEUTICS : to Host Conference Call and Webcast to Discuss Fourth Qua..
BU
02/06AIMMUNE THERAPEUTICS : Nestle Health Science further invests in Aimmune Therapeu..
AQ
02/06AIMMUNE THERAPEUTICS : Announces Additional $200 Million Equity Investment by Ne..
AQ
02/06AIMMUNE THERAPEUTICS : Licenses Exclusive Worldwide Rights to Xencor's XmAb7195 ..
AQ
02/05AIMMUNE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creatio..
AQ
02/05AIMMUNE THERAPEUTICS : Announces Additional $200 Million Equity Investment by Ne..
BU
02/03AIMMUNE THERAPEUTICS : FDA Approves Aimmune's PALFORZIA as First Treatment for P..
AQ
01/31AIMMUNE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (fo..
AQ
01/31AIMMUNE THERAPEUTICS : FDA Approves Aimmune's PALFORZIA™ as First Treatmen..
BU
01/06AIMMUNE THERAPEUTICS : to Present at the 38th Annual J.P. Morgan Healthcare Conf..
BU
2019AIMMUNE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financia..
AQ
2019AIMMUNE THERAPEUTICS : to Participate in Three Upcoming Investor Conferences
AQ
2019AIMMUNE THERAPEUTICS : to Participate in Three Upcoming Investor Conferences
BU
2019AIMMUNE THERAPEUTICS : Quality of Life Outcomes from Two New Surveys Highlight E..
BU
2019AIMMUNE THERAPEUTICS : New Data Presented at ACAAI 2019 Show Importance of Clini..
BU
2019AIMMUNE THERAPEUTICS : AR101 Demonstrates Consistent Efficacy and Safety in New ..
BU
2019AIMMUNE THERAPEUTICS : New Real-World Data Unveiled at ACAAI Indicates Comparabl..
BU
1  2  3Next
Upcoming event on AIMMUNE THERAPEUTICS, INC.